Laboratory specialist Synlab increases sales target for 2022

MUNICH (dpa-AFX) – The laboratory specialist SYNLAB increased its sales target for 2022 in the first quarter due to continued high demand for Covid-19 tests, among other things. Synlab is now expecting revenues of around 3.1 billion euros for the current year, as the SDAX-listed company announced on Thursday in Munich. Previously, the Munich company had around three billion in its sights after 3.76 billion euros in the previous year.

The company is also becoming a little more optimistic about the margin. At least 24 percent of sales should now remain, which is one percentage point more than adjusted earnings before interest, taxes, depreciation and amortization. Synlab continues to expect an adjusted Ebitda margin of 25 percent at most. In 2021, 32.1 percent of sales remained as adjusted Ebitda.

In the first quarter, revenues increased by 13.1 percent year-on-year to 1.06 billion euros. Earnings before interest, taxes, depreciation and amortization (Ebitda) adjusted for special effects rose by 10.1 percent to 356.9 million euros. The corresponding margin was 33.6 percent./mne/eas